Graham Kenneth Crompton

Graham Kenneth Crompton's AcademicInfluence.com Rankings

Chemistry

#4545

World Rank

#5628

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Graham Kenneth Crompton's Degrees

PhD Pharmaceutical Sciences University of Manchester
Masters Pharmaceutical Sciences University of Manchester
Bachelors Pharmacy University of Manchester

Why Is Graham Kenneth Crompton Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Graham Kenneth Crompton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. (2008) (574)
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. (2001) (558)
Problems patients have using pressurized aerosol inhalers. (1982) (384)
Importance of inhaler devices in the management of airway disease. (2008) (294)
The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. (2006) (272)
Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. (2000) (261)
Use of pressurised aerosols by asthmatic patients. (1976) (228)
Letter: Beclomethasone aerosol in chronic bronchial asthma. (1974) (227)
Management of Severe Asthma (1998) (182)
Glucocorticoid resistance in asthma. (1995) (152)
What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. (1983) (143)
Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. (1995) (142)
A brief history of inhaled asthma therapy over the last fifty years. (2006) (133)
Retail sales of inhalation devices in European countries: so much for a global policy. (2011) (131)
The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness. (2009) (128)
Corticosteroid resistance in chronic asthma (1981) (123)
Corticosteroid resistance in chronic asthma. (1981) (109)
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? (1990) (105)
Regular inhaled salbutamol and asthma control: the TRUST randomised trial (2000) (104)
Cutaneous vasoconstrictor response to glucocorticoids in asthma (1991) (101)
The ADMIT series - issues in inhalation therapy. 6) Training tools for inhalation devices. (2010) (98)
Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. (1991) (95)
Proinflammatory cytokines in acute asthma (1991) (95)
Sarcoidosis: a disorder commoner in non-smokers? (1986) (93)
Peak inspiratory flow through Turbuhaler in acute asthma. (1995) (84)
Substitution of Beclomethasone Aerosol for Oral Prednisolone in the Treatment of Chronic Asthma (1973) (79)
Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. (1991) (79)
Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? (1989) (74)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) (2016) (73)
Edinburgh Emergency Asthma Admission Service: report on 10 years' experience. (1979) (71)
Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. (1979) (66)
A tube spacer to improve inhalation of drugs from pressurised aerosols. (1979) (65)
Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. (1982) (64)
A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma (1968) (60)
Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. (1993) (60)
Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. (1993) (60)
SARCOIDOSIS AND COELIAC DISEASE: AN ASSOCIATION? (1984) (55)
Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis? (1993) (54)
Dry powder inhalers: advantages and limitations. (1991) (54)
An unusual example of exercise-induced asthma (1968) (53)
The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma. (2010) (51)
Penicillium allergic alveolitis: faulty installation of central heating. (1984) (50)
The ADMIT series--issues in inhalation therapy. 3) Mild persistent asthma: the case for inhaled corticosteroid therapy. (2009) (50)
Beclomethasone Dipropionate and Oropharyngeal Candidiasis (1974) (48)
The impact of chemotherapy on small cell carcinoma of the bronchus. (1986) (47)
An objective assessment of the tube spacer in patients unable to use a conventional pressurized aerosol efficiently. (1981) (47)
Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. (1976) (47)
Corticosteroid treatment and prognosis in pulmonary eosinophilia. (1989) (46)
Assisted ventilation in severe acute asthma. (1986) (45)
COMPARISON OF THE BRONCHODILATOR EFFECTS OF SALBUTAMOL INHALED AS A DRY POWDER AND BY CONVENTIONAL PRESSURISED AEROSOL (1977) (44)
Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease. (1999) (44)
Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. (1999) (44)
Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisolone-sparing effects. (1985) (43)
How to achieve good compliance with inhaled asthma therapy. (2004) (43)
Edinburgh emergency asthma admission service. (1975) (42)
The Use of Electronic Diaries in Respiratory Studies (1997) (39)
Observations on the management of acute bronchial asthma. (1979) (39)
Dose of inhaled budesonide required to produce clinical suppression of plasma cortisol. (1987) (35)
Clinical assessment of a new breath-actuated inhaler. (1989) (34)
Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? (1985) (34)
Pulmonary fibrosis, pulmonary tuberculosis and ankylosing spondylitis. (1974) (33)
Suxamethonium is dangerous in polyneuropathy. (1981) (32)
Original article: Potentiation of cisplatin by alpha-Interferon in advanced non-small cell lung cancer (NSCLC): A phase II study (1990) (32)
Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma. (1995) (31)
Two unusual organisms, Aspergillus terreus and Metschnikowia pulcherrima, associated with the lung disease of ankylosing spondylitis (1972) (31)
Small cell lung cancer. (1990) (30)
The adult patient’s difficulties with inhalers (2007) (29)
Upper lobe fibrosis and cavitation in rheumatoid disease. (1980) (28)
Treatment of bronchopulmonary aspergillosis with clotrimazole. (1973) (28)
Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma. (2008) (27)
The use of a new breath-actuated inhaler by patients with severe airflow obstruction. (1991) (27)
Tuberculosis of the thyroid gland mimicking carcinoma. (1969) (26)
Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. (1992) (25)
Response to Rimiterol and Salbutamol Aerosols Administered by Intermittent Positive-pressure Ventilation (1974) (25)
Non-tuberculous pulmonary infections in Scotland: a cluster in Lothian? (1995) (24)
Salbutamol in the treatment of asthma. (1979) (24)
Breath-actuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler. (1989) (24)
Highdose inhaled steroid therapy and the cortisol stress response to acute severe asthma (1992) (24)
Beclomethasone dipropionate dry-powder inhalation compared with conventional aerosol in chronic asthma. (1978) (24)
Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis. (1989) (23)
Edinburgh Emergency Asthma Admission Service: report on 15 years' experience. (1987) (22)
Is the flow rate used to drive a jet nebuliser clinically important? (1985) (22)
Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. (1984) (21)
The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device. (1997) (20)
Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination? (1994) (20)
Corticosteroids and bone mass in asthma. (1987) (20)
Para-aminosalicylic acid as a cause of intestinal malabsorption. (1968) (20)
Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia. (2000) (20)
Electronic diaries for asthma (1995) (18)
Dermatomyositis and rapidly progressive fibrosing alveolitis. (1983) (18)
Pneumocystis carinii in bronchoalveolar lavage fluid and bronchial washings (1994) (17)
Nebulized or intravenous beta 2 adrenoceptor agonist therapy in acute asthma? (1990) (17)
Use of Pen-Based Electronic Diaries in an International Clinical Trial of Asthma (2000) (17)
The catastrophic asthmatic. (1987) (17)
Emergency pre-hospital management of patients admitted with acute asthma (2000) (17)
Inhaler choice and inhalation technique: key factors for asthma control. (2009) (16)
β2-agonists in asthma (1991) (15)
Primary leiomyosarcoma of the lung presenting with a persistent pneumothorax. (1986) (15)
Rigid bronchoscopy under intravenous general anaesthesia with oxygen Venturi ventilation. (1982) (14)
Failure to Differentiate Pulmonary Infarction from Pneumonia by Biochemical Tests (1966) (14)
Non-Hodgkin's Lymphoma of the Lung (1988) (14)
SPUTUM VISCOSITY AND LONG-TERM IPRATROPIUM BROMIDE NEBULISER THERAPY (1982) (13)
A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma. (1986) (13)
HYPOTHALAMO‐PITUITARY‐ADRENAL AXIS SUPPRESSION IN ASTHMATIC ADULTS TAKING HIGH DOSE BECLOMETHASONE DIPROPIONATE (1992) (13)
Chronic bronchitis: is bacteriological examination of sputum necessary? (1978) (13)
Association may not be causal (1996) (12)
Moving from CFC Aerosol to HFA Aerosol or Dry Powder Inhalers: What Do Patients Think? (2002) (12)
The forced expiratory volume after hyperventilation in bronchitis and asthma. (1968) (12)
Nebulized salbutamol in life-threatening asthma: is IPPB necessary? (1983) (12)
Breath-activated aerosol. (1971) (11)
Treatment of Asthma with Beclomethasone Aerosol (1972) (11)
Comparative efficacy and potency of ipratropium via Turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction. (1997) (11)
Inappropriate antidiuretic hormone secretion in oat-cell carcinoma of bronchus (1972) (11)
Prolonged Q fever associated with inappropriate secretion of anti-diuretic hormone. (1984) (10)
High dose inhaled steroid therapy and the cortisol stress response to acute severe asthma. (1992) (10)
Clinical Assessment of a New Multidose Nonpressurised Metered-Dose Inhaler (1990) (10)
Asthma: Clinical Features (2008) (10)
The measurement of endomural bronchial (or "squeeze") pressures in bronchitis and asthma. (1966) (9)
Terminal ileitis due to Yersinia pseudotuberculosis. (1976) (9)
Potentiation of cisplatin by alpha-interferon in advanced non-small cell lung cancer (NSCLC): a phase II study. (1990) (8)
Comparison of terbutaline via the Nebuhaler and salbutamol via the Volumatic: theory and practice. (1990) (7)
Treatment for acute asthma in the ambulance. (1990) (7)
Comparison of fenoterol and terbutaline administered by intermittent positive pressure breathing. (1980) (7)
Diagnosis and Management of Respiratory Diseases (1980) (7)
Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma. (1982) (7)
New inhalation devices. (1988) (7)
Soft tissue sarcoma: two cases of solitary lung metastasis more than 15 years after diagnosis. (1986) (7)
Pet ownership and asthma morbidity. (2000) (7)
Pulmonary fibrosis, mimicking tuberculosis, presenting before joint symptoms in a female with ankylosing spondylitis. (1973) (7)
Hypersensitivity pneumonitis associated with co-proxamol (paracetamol + dextropropoxyphene) therapy (1999) (6)
Aerosol delivery devices. (2006) (6)
BECLOMETHASONE AEROSOL IN CHRONIC BRONCHIAL ASTHMA (1974) (6)
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer (2004) (6)
Pulmonary eosinophilia after substitution of aerosol for oral corticosteroid therapy. (1975) (6)
Severe hypoglycaemia in the course of treatment with streptomycin, isoniazid and ethionamide. (1967) (6)
Illogical warnings on Ventolin inhalers. (1984) (6)
Letter: Adrenal failure in bronchial asthma. (1973) (5)
Starting home nebulizer therapy: patients' expectations and subsequent outcome at 2 months. (1998) (5)
Objective and subjective comparisons of terbutaline and rimiterol bronchodilator aerosols. (1975) (5)
Medical personnel's knowledge of the ability to use inhaling devices. (1995) (5)
Letter: Aerosols and asthma deaths. (1973) (5)
The heart in the Guillain-Barré syndrome (1984) (5)
Pulmonary eosinophilia with systemic features: therapy and prognosis. (1992) (5)
Cyclophosphamide in Disseminated Bronchial Carcinoma (1974) (5)
Issues in inhalation therapy: a new series of papers from the ADMIT Working Group. (2007) (5)
Clinical use of dry powder systems. (1982) (5)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). (2016) (4)
Fenfluramine in corticosteroid-induced obesity. (1972) (4)
Fibrinolytic, factor VIII and pulse rate responses to intravenous adrenaline during chronic oral salbutamol administration (1973) (4)
Artificial ventilation for neurological disease: retrospective analysis 1972-81. (1983) (4)
Unusual radiographic abnormalities observed during treatment of tuberculous pleural effusion. (1974) (4)
Evaluation of the combination inhaler of salbutamol and beclomethasone dipropionate in the management of asthma. (1988) (4)
Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated. (1993) (3)
The effect of antispasmodic drugs on the endomural bronchial (or "squeeze") pressures in bronchitis and asthma. (1966) (3)
Matching inhalers and spacer devices (1994) (3)
Benzodiazepine-opiate antagonism — a problem in intensive-care therapy (2004) (3)
Unusual pulmonary reactions to oily propyliodone (Dionosil) in bronchography. (1983) (3)
Letter: Death in asthma. (1975) (3)
Further studies of rimiterol and salbutamol administered by intermittent positive-pressure ventilation, and an important observation on the technique of using the Bennett ventilator. (1977) (3)
Severe acute asthma--a problem patient. (1982) (2)
Ventilatory failure in Guillain-Barré syndrome: indications for assisted ventilation in neurological diseases (1981) (2)
General anesthesia for rigid bronchoscopy how safe (1981) (2)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) (2016) (2)
Inhalation Flows in Adult Patient Populations, Including Those With Acute Asthma (1997) (2)
Enprofylline in chronic asthma. (1988) (2)
Efficacy of a new nystatin formulation in oral candidiasis (1986) (2)
The late results of consolidation treatment following induction chemotherapy for small cell lung cancer (1991) (2)
Bambuterol is a more cost-effective treatment strategy than salmeterol in asthmatic patients with nocturnal symptoms (1999) (2)
Disseminated infection with mycobacterium avium: Part III—Sensitivity to avian tuberculin among contacts (1968) (2)
Special problems of clinical trials in status asthmaticus [proceedings]. (1977) (1)
PIRBUTEROL (1984) (1)
Steroids in respiratory disease. (1982) (1)
Glucocorticoid-Induced Skin Blanching: A Useful Test in Predicting Responsiveness of Bronchial Asthma to Glucocorticoid Therapy (1990) (1)
Effectiveness of four different inhalers in COPD. (1996) (1)
Deaths from asthma on holiday (1981) (1)
Comparison of Pulmicort 1 pMDI plus Nebuhaler 1 and Pulmicort 1 Turbuhaler 1 in asthmatic patients with dysphonia (2000) (1)
Drug delivery: matching devices to patients. (1995) (1)
How to achieve good compliance with inhaled asthma therapy (2006) (1)
Misleading guidelines on oxygen treatment in asthma. (1985) (1)
Whathappens topatients withpulmonary aspergilloma? Analysis of23cases (1983) (1)
The ISOLDE trial. Pharmaceutical companies should admit high cost of treatment. (2000) (1)
Fluticasone propionate bioavailability in asthma (2000) (1)
Hyperventilation in men claiming compensation for benign asbestos-related diseases. (2010) (1)
Emphysema, cirrhosis, and heart block in a young patient with partial alpha 1 antitrypsin deficiency (PiMZ phenotype). (1985) (1)
Misleading guidelines on oxygen treatment in asthma (1985) (1)
Anunusual example ofexercise-induced asthma (1968) (1)
Reply to the letter from Dr Leitch (1993) (0)
Effectiveness ofnebulised salbutamol administered inambulances topatients with severeacuteasthma (1995) (0)
Acknowledgement to reviewers 2009 (2010) (0)
Treatment of bromhopulmoiiarv asnergillosis with clotriniazole. (1973) (0)
BAMBUTEROL IS A MORE COST-EFFECTIVE STRATEGY THAN SALMETEROL IN ASTHMATIC PATIENTS WITH NOCTURNAL SYMPTOMS (1999) (0)
Oropharyngeal thrush and beclomethasone dipropionate. (1975) (0)
Delay in publishing ABPI Code of Practice Committee rulings (1980) (0)
Terbutaline aerosol given through pear spacer in acute severe asthma (1982) (0)
Nebulised salbutamol in life-threatening asthma (1979) (0)
Management of Deep Vein Thrombosis (1970) (0)
Bromocriptine in severe adult asthma--a negative report. (1983) (0)
Inhaler technique blind spot (2006) (0)
Chest physiotherapy in primary pneumonia (1985) (0)
Letter: Treatment of aspergillosis. (1974) (0)
Ethics of drug promotion. (1979) (0)
Patients with Squamous Cell Bronchial Carcinoma Have Normal Nk Cell Numbers but Altered T Lymphocyte Subpopulations (1987) (0)
Malabsorption Induced by P.A.S (1969) (0)
Making the diagnosis of asthma. Trial of steroids is useful. (1998) (0)
Acknowledgements (2004) (0)
The article by Daley-Yates et al. (2010) (0)
Pp. 433. Price 21.50Terry Des Jardins, Clinical Manifestations of Respiratory Disease (1st edition), Year Book Medical Publishers, Inc., Philadelphia (1984). (1985) (0)
Dolarge volume spacerdevices reduce the systemic effects ofhighdoseinhaled corticosteroids (1990) (0)
HYPOTHALAMO-PITUITARY-ADRENAL AXIS SUPPRESSION IN ASTHMATICS. AUTHOR'S REPLY (1993) (0)
Artificial ventilation for neurological disease (1983) (0)
Becloforte inhaler. (1983) (0)
Chapter 35. Asthma: Management (2008) (0)
Disseminated infection with Mycobacterium avium: 3. Sensitivity to avian tuberculin among contacts. (1968) (0)
Acknowledgement to reviewers 2009 (2009) (0)
Acknowledgments (1987) (0)
Primary leiomyosarcoma ofthelung presenting with apersistent pneumothorax (1986) (0)
The effect of epinephrine and of the supine position on esophageal pressure recordings. (1966) (0)
malmoense and aspergillus infection: afatal combination? (1994) (0)
Fluticasone propionate bioavailability in asthma [1] (multiple letters) (2000) (0)
Medical respiratory emergencies. (1981) (0)
Inhalation devices. (1982) (0)
Diagnosis of adrenal insufficiency (1989) (0)
Clinical manifestations of respiratory disease (1985) (0)
Acknowledgements (1997) (0)
Systemic effects ofhighdoseinhaled steroids: comparison ofbeclomethasone dipropionate and budesonide inhealthy subjects (1993) (0)
PGD10 Bambuterol is a More Cost-Effective Treatment than Salmeterol in Asthma Patients with Nocturnal Symptoms (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Graham Kenneth Crompton?

Graham Kenneth Crompton is affiliated with the following schools:

University of Edinburgh